Market Wrap
A day split between biotech momentum and infrastructure capital deployment. The weight fell on companies with binary catalysts—trial outcomes and expansion commitments—that moved large-cap equities on fundamental news rather than macro shifts.
- Moderna's cancer vaccine clears Phase 3 trial against standard treatment
- Micron commits to major Boise expansion, strains regional housing and traffic
Sources: Cointelegraph, CoinDesk, CNBC, Decrypt, The Block, MarketWatch, The Defiant
This article is for information only and is not financial advice.
What the market did
Each figure is this site’s own reading, with what it was measured against. A blank is a reading nobody took, not a zero. The before-the-headline window prints the rate a RANDOM hour clears the same bar, because a hit rate without its null is not a finding.
Cite this
Archived copy · an independent capture of this page at the Internet Archive, kept so this report can be checked against what it said on the day
← more bytes